Cancer Research UK to conduct first-in-man study of GSK drug

Wednesday 20 May 2009

Cancer Research UK has agreed to conduct a first-in-man study of a novel anti-cancer drug owned by GlaxoSmithKline, but not currently a priority of the UK multinational.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom